From: Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study
Gender | Age by diagnosis | ||||||||
---|---|---|---|---|---|---|---|---|---|
Male | Female | p rate | 0–49 years | 50–59 years | 60–69 years | 70–79 years | 80 years and above | p rate | |
Malignant neoplasm of the colon [appendix] (C18.1) | 220 (40.1%) | 329 (59.9%) | < 0.001 | 215 (39.2%) | 68 (12.4%) | 135 (24.6%) | 85 (15.5%) | 46 (8.4%) | < 0.001 |
Malignant neoplasm of specified parts of the peritoneum (C48.1) | 22 (36.1%) | 39 (63.9%) | 0.030 | 9 (14.8%) | 11 (18.0%) | 18 (29.5%) | 15 (24.6%) | 8 (13.1%) | 0.214 |
Malignant neoplasm of the peritoneum, unspecified (C48.2) | 26 (22.0%) | 92 (78.0%) | < 0.001 | 10 (8.5%) | 18 (15.3%) | 41 (34.7%) | 25 (21.2%) | 24 (20.3%) | < 0.001 |
Overlapping lesion of the retroperitoneum and peritoneum (C48.8) | 21 (41.2%) | 30 (58.8%) | 0.208 | 3 (5.9%) | 8 (15.7%) | 18 (35.3%) | 12 (23.5%) | 10 (19.6%) | 0.019 |